Insulin-like growth factor-I gene therapy reverses morphologic changes and reduces hyperprolactinemia in experimental rat prolactinomas

BACKGROUND: The implementation of gene therapy for the treatment of pituitary tumors emerges as a promising complement to surgery and may have distinct advantages over radiotherapy for this type of tumors. Up to now, suicide gene therapy has been the main experimental approach explored to treat expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Console, Gloria M, Herenu, Claudia B, Camihort, Gisela A, Luna, Georgina C, Bracamonte, Maria I, Morel, Gustavo R, Goya, Rodolfo G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2263076/
https://www.ncbi.nlm.nih.gov/pubmed/18218140
http://dx.doi.org/10.1186/1476-4598-7-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2263076/
https://www.ncbi.nlm.nih.gov/pubmed/18218140
http://dx.doi.org/10.1186/1476-4598-7-13

Ejemplares similares